1998
DOI: 10.1097/00007890-199806270-00667
|View full text |Cite
|
Sign up to set email alerts
|

ARE PROFESSIONAL ANTIGEN PRESENTING CELLS (APCs) NECESSARY TO INITIATE GRAFT REJECTION?

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2020
2020
2020
2020

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 0 publications
0
1
0
Order By: Relevance
“…60 In contrast, Apligraf, an avascular bilayered skin equivalent approved by FDA, does not induce acute rejection responses likely due to the fact that it lacks both professional antigenpresenting cells and ECs. [61][62][63] While grafts containing unmodified human ECs will be alloimmunogenic, this property can be eliminated from HECFC-derived ECs by CRISPR/Cas9mediated deletion of HLA antigen expression. [64][65][66] We anticipate that successful engraftment of a 3D bioprinted human skin graft by incorporating allogeneic ECs without triggering rejection in the host would be of great clinical utility and the basis for the creation of an ''off-the-shelf'' clinical product.…”
Section: D Bioprinting Of Vascularized Human Skin Graftmentioning
confidence: 99%
“…60 In contrast, Apligraf, an avascular bilayered skin equivalent approved by FDA, does not induce acute rejection responses likely due to the fact that it lacks both professional antigenpresenting cells and ECs. [61][62][63] While grafts containing unmodified human ECs will be alloimmunogenic, this property can be eliminated from HECFC-derived ECs by CRISPR/Cas9mediated deletion of HLA antigen expression. [64][65][66] We anticipate that successful engraftment of a 3D bioprinted human skin graft by incorporating allogeneic ECs without triggering rejection in the host would be of great clinical utility and the basis for the creation of an ''off-the-shelf'' clinical product.…”
Section: D Bioprinting Of Vascularized Human Skin Graftmentioning
confidence: 99%